ESC Premium Access

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Congress Presentation

About the speaker

Associate Professor Francisco Marin

Virgen of the Arrixaca University Hospital, Murcia (Spain)
3 presentations
0 follower

5 more presentations in this session

Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis

Speaker: Professor D. Sibbing (Munich, DE)


One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)


Ischemic-bleeding balance according to history of prior bleeding in patients with acute coronary syndrome during treatment with dual antiplatelet therapy

Speaker: Ms B. Caneiro-Queija (Vigo, ES)


Percutaneous coronary intervention in the age of frailty

Speaker: Doctor M. Bergami (Bologna, IT)


Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)


Access the full session

Insights from acute coronary syndrome registries

Speakers: Associate Professor F. Marin, Professor D. Sibbing, Doctor M. Esteve Pastor, Ms B. Caneiro-Queija, Doctor M. Bergami...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb